Mylan responds to senator's inquiry on EpiPen price increase
MLex Summary: Mylan Pharmaceuticals has responded to US Senator Chuck Grassley’s inquiry as to an increase in the price of EpiPens. Mylan listed how it determined the price of EpiPens, its advertising...To view the full article, register now.
Already a subscriber? Click here to view full article